These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29215406)

  • 1. Focal 18F-DOPA Uptake in Brain Parenchyma Surrounding Developmental Venous Anomalies.
    Condon L; Blazak J
    Clin Nucl Med; 2018 Feb; 43(2):e37-e38. PubMed ID: 29215406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-DOPA Uptake of Developmental Venous Anomalies in Children With Brain Tumors.
    Morana G; Piccardo A; Garrè ML; Cabria M; Rossi A
    Clin Nucl Med; 2016 Jul; 41(7):e351-2. PubMed ID: 26909711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seizure-Induced Increased 18F-DOPA Uptake in a Child With Diffuse Astrocytoma and Transient Brain MRI Abnormalities Related to Status Epilepticus.
    Morana G; Bottoni G; Mancardi MM; Verrico A; Piccardo A
    Clin Nucl Med; 2018 May; 43(5):e149-e150. PubMed ID: 29465492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study.
    Morana G; Piccardo A; Milanaccio C; Puntoni M; Nozza P; Cama A; Zefiro D; Cabria M; Rossi A; Garrè ML
    J Nucl Med; 2014 May; 55(5):718-23. PubMed ID: 24652828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.
    Morana G; Piccardo A; Tortora D; Puntoni M; Severino M; Nozza P; Ravegnani M; Consales A; Mascelli S; Raso A; Cabria M; Verrico A; Milanaccio C; Rossi A
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2084-2093. PubMed ID: 28752225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-DOPA PET/CT Physiological Distribution and Pitfalls: Experience in 215 Patients.
    Calabria FF; Chiaravalloti A; Jaffrain-Rea ML; Zinzi M; Sannino P; Minniti G; Rubello D; Schillaci O
    Clin Nucl Med; 2016 Oct; 41(10):753-60. PubMed ID: 27454592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
    Kauhanen S; Seppänen M; Minn H; Gullichsen R; Salonen A; Alanen K; Parkkola R; Solin O; Bergman J; Sane T; Salmi J; Välimäki M; Nuutila P
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1237-44. PubMed ID: 17227804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there an optimal scan time for 6-[F-18]fluoro-L-DOPA PET in pheochromocytomas and paragangliomas?
    Hentschel M; Rottenburger C; Boedeker CC; Neumann HP; Brink I
    Clin Nucl Med; 2012 Feb; 37(2):e24-9. PubMed ID: 22228360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas.
    Magnaldi S; Mayerhoefer ME; Khameneh A; Schuetz M; Javor D; Mitterhauser M; Dudczak R; Hacker M; Karanikas G
    Anticancer Res; 2014 Feb; 34(2):791-5. PubMed ID: 24511014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.
    Zani A; Nah SA; Ron O; Totonelli G; Ismail D; Smith VV; Ashworth M; Blankenstein O; Mohnike W; De Coppi P; Eaton S; Hussain K; Pierro A
    J Pediatr Surg; 2011 Jan; 46(1):204-8. PubMed ID: 21238668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspective.
    Walter F; Cloughesy T; Walter MA; Lai A; Nghiemphu P; Wagle N; Fueger B; Satyamurthy N; Phelps ME; Czernin J
    J Nucl Med; 2012 Mar; 53(3):393-8. PubMed ID: 22323780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
    Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W
    J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma.
    Morana G; Puntoni M; Garrè ML; Massollo M; Lopci E; Naseri M; Severino M; Tortora D; Rossi A; Piccardo A
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1664-72. PubMed ID: 26911489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferred transport of O-(2-[18F]fluoroethyl)-D-tyrosine (D-FET) into the porcine brain.
    Makrides V; Bauer R; Weber W; Wester HJ; Fischer S; Hinz R; Huggel K; Opfermann T; Herzau M; Ganapathy V; Verrey F; Brust P
    Brain Res; 2007 May; 1147():25-33. PubMed ID: 17343835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT.
    Calabria F; Chiaravalloti A; Di Pietro B; Grasso C; Schillaci O
    Nucl Med Commun; 2012 Jun; 33(6):563-70. PubMed ID: 22395034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of 18F-DOPA PET imaging in the detection of brain tumor recurrence.
    Calabria F; Cascini GL
    Hell J Nucl Med; 2015; 18(2):152-6. PubMed ID: 26187216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDOPA kinetics in brain tumors.
    Schiepers C; Chen W; Cloughesy T; Dahlbom M; Huang SC
    J Nucl Med; 2007 Oct; 48(10):1651-61. PubMed ID: 17873130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-DOPA positron emission tomography for the detection of glomus tumours.
    Hoegerle S; Ghanem N; Altehoefer C; Schipper J; Brink I; Moser E; Neumann HP
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):689-94. PubMed ID: 12618904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.
    Rischke HC; Benz MR; Wild D; Mix M; Dumont RA; Campbell D; Seufert J; Wiech T; Rössler J; Weber WA; Neumann HP
    J Nucl Med; 2012 Sep; 53(9):1352-8. PubMed ID: 22836345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-Dopa as an amino acid tracer to detect brain tumors.
    Heiss WD; Wienhard K; Wagner R; Lanfermann H; Thiel A; Herholz K; Pietrzyk U
    J Nucl Med; 1996 Jul; 37(7):1180-2. PubMed ID: 8965194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.